Sylvester Comprehensive Cancer Center - University of Miami /ID# 255856

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion	Nutritional and Metabolic Diseases, amyloidosis, metabolic disease, proteostasis deficiencies	Recruiting	Phase 1 / Phase 2	2026-05-13		NCT06158854

Clinical trials